BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//ORION Biotech Catalyst Calendar//company//EN
CALSCALE:GREGORIAN
X-WR-CALNAME:ORION — VTRS stated timing
X-WR-CALDESC:Exact dates VTRS stated in SEC filings\, quoted as written\, w
 ith SEC links. No forecasts.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:orion-event-FDA20261030-VTRS-FDA-DECISION@orionbiotechai.com
SEQUENCE:1
DTSTAMP:20261029T000000Z
LAST-MODIFIED:20261029T000000Z
DTSTART;VALUE=DATE:20261227
DTEND;VALUE=DATE:20261228
SUMMARY:VTRS MR-107A-02 (fast-acting meloxicam): FDA decision\, “December
  27\, 2026”
DESCRIPTION:Viatris Inc (VTRS)\, MR-107A-02 (fast-acting meloxicam): PDUFA 
 target action date.\nCompany wording\, as written: “The FDA has assigned
  a PDUFA goal date of December 27\, 2026.”\nStated period: “December 2
 7\, 2026”.\nFiled 2026-08-06\, SEC Form 8-K\, EX-99.1.\nSEC filing: http
 s://www.sec.gov/Archives/edgar/data/1792044/000179204426000037/exhibit991-
 2q26earningsrel.htm\nORION page: https://www.orionbiotechai.com/company/VT
 RS?src=ics\nORION records what the company wrote. It is not a forecast.
URL:https://www.orionbiotechai.com/company/VTRS?src=ics
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR